AAV9-hBGAL gene therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AAV9-hBGAL gene therapy, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Prenatal Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis Clinical Trial [Phase 1]